Biocept Total Liabilities

Biocept (BIOC) currently reports a total liabilities of $22M as of June 2023. That compares with $26M in the prior-year period — down 15.1% year over year. Use the charts on this page to explore Biocept's total liabilities history and peer comparisons.

Biocept's total liabilities decreased from $26M to $22M — a 15.1% year-over-year decrease (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Biocept reported $22M in total liabilities as of June 2023. That compares with $26M in the prior-year period — down 15.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $22M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Biocept, and consider following BIOC for alerts when major investors trade the stock.

Biocept is classified in the Healthcare sector. On total liabilities, it currently shows $22M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BIOC with unrelated industries.